Table 2.
Polymorphism | Genotype | BRCA1/2 MBC cases (n = 89) | Unaffected male BRCA1/2 mutation carriers (n = 157) | OR (95% CI) | P value | ||
---|---|---|---|---|---|---|---|
n | % | n | % | ||||
CYP17A1 c.-34T>C | TT | 31 | 34.8 | 57 | 36.3 | Ref | |
rs743572 | TC | 48 | 53.9 | 71 | 45.2 | 1.08 (0.53–2.20) | 0.83 |
CC | 10 | 11.3 | 29 | 18.5 | 0.81 (0.29–2.23) | 0.68 | |
Co-dominant | 0.94 (0.59–1.50) | 0.79 | |||||
CYP1B1 p.Leu432Val | GG | 34 | 38.2 | 67 | 42.7 | Ref | |
rs1056836 | GC | 44 | 49.4 | 70 | 44.6 | 1.42 (0.71–2.86) | 0.32 |
CC | 11 | 12.4 | 20 | 12.7 | 0.62 (0.20–1.92) | 0.41 | |
Co-dominant | 0.95 (0.59–1.54) | 0.83 | |||||
CYP1B1 p.Asn453Ser | AA | 53 | 59.5 | 96 | 61.2 | Ref | |
rs1800440 | AG | 32 | 36.0 | 55 | 35.0 | 1.44 (0.72–2.91) | 0.31 |
GG | 4 | 4.5 | 6 | 3.8 | 2.97 (0.71–12.38) | 0.13 | |
Co-dominant | 1.57 (0.91–2.73) | 0.11 |